Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF

Marco D'Imperio, Anna Della Corte, Angelo Facchiano, Michela Di Michele, Gabriella Ferrandina, Maria B. Donati, Domenico Rotilio

Research output: Contribution to journalArticle

Abstract

A growing body of literature defines MALDI-TOF MS as a technique for studying plasma and serum, thus enabling the detection of proteins, and the generation of reproducible protein profile mass spectra, potentially able to discriminate correctly different biological systems. In this work, the different steps of the pre-analytical phase that may affect the reproducibility of plasma proteome analysis have been carefully considered. The results showed that the method is highly accurate (9.1%) and precise (8.9%) and the calibration curve for the ACTH (18-39), in human plasma, gave a good correlation coefficient (r > 0.99 and r2 > 0.98). The limit of detection (LOD) and the limit of quantification (LOQ), relative intensity, were of 0.5 × 10-9 M and 1.0 × 10-9 M respectively. Thus, an assay has been developed for the detection of low-abundant and low molecular weight proteins, from human plasma, aiming at the identification of new potential biomarkers. The method was tested on plasma from patients with a first diagnosis of pelvic mass. Statistical analysis of plasma profile generated a sub-profile of 17 peptides with their relative abundance able to discriminate patients bearing malignant or benign tumors. The sensitivity and specificity were 85.7% and 80.0% respectively.

Original languageEnglish
Pages (from-to)1355-1367
Number of pages13
JournalJournal of Proteomics
Volume73
Issue number7
DOIs
Publication statusPublished - May 7 2010

Fingerprint

Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Plasma (human)
Plasmas
Corticotropin-Like Intermediate Lobe Peptide
Bearings (structural)
Proteins
Biomarkers
Biological systems
Proteome
Tumors
Assays
Statistical methods
Molecular weight
Calibration
Limit of Detection
Blood Proteins
Peptides
Molecular Weight
Sensitivity and Specificity
Serum

Keywords

  • Accuracy
  • Biomarkers
  • LOD-LOQ
  • MALDI-TOF MS
  • Plasma profile
  • Precision

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics

Cite this

Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF. / D'Imperio, Marco; Della Corte, Anna; Facchiano, Angelo; Di Michele, Michela; Ferrandina, Gabriella; Donati, Maria B.; Rotilio, Domenico.

In: Journal of Proteomics, Vol. 73, No. 7, 07.05.2010, p. 1355-1367.

Research output: Contribution to journalArticle

D'Imperio, M, Della Corte, A, Facchiano, A, Di Michele, M, Ferrandina, G, Donati, MB & Rotilio, D 2010, 'Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF', Journal of Proteomics, vol. 73, no. 7, pp. 1355-1367. https://doi.org/10.1016/j.jprot.2010.03.001
D'Imperio, Marco ; Della Corte, Anna ; Facchiano, Angelo ; Di Michele, Michela ; Ferrandina, Gabriella ; Donati, Maria B. ; Rotilio, Domenico. / Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF. In: Journal of Proteomics. 2010 ; Vol. 73, No. 7. pp. 1355-1367.
@article{5d949a0c30b34032b0958ff2b84127e2,
title = "Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF",
abstract = "A growing body of literature defines MALDI-TOF MS as a technique for studying plasma and serum, thus enabling the detection of proteins, and the generation of reproducible protein profile mass spectra, potentially able to discriminate correctly different biological systems. In this work, the different steps of the pre-analytical phase that may affect the reproducibility of plasma proteome analysis have been carefully considered. The results showed that the method is highly accurate (9.1{\%}) and precise (8.9{\%}) and the calibration curve for the ACTH (18-39), in human plasma, gave a good correlation coefficient (r > 0.99 and r2 > 0.98). The limit of detection (LOD) and the limit of quantification (LOQ), relative intensity, were of 0.5 × 10-9 M and 1.0 × 10-9 M respectively. Thus, an assay has been developed for the detection of low-abundant and low molecular weight proteins, from human plasma, aiming at the identification of new potential biomarkers. The method was tested on plasma from patients with a first diagnosis of pelvic mass. Statistical analysis of plasma profile generated a sub-profile of 17 peptides with their relative abundance able to discriminate patients bearing malignant or benign tumors. The sensitivity and specificity were 85.7{\%} and 80.0{\%} respectively.",
keywords = "Accuracy, Biomarkers, LOD-LOQ, MALDI-TOF MS, Plasma profile, Precision",
author = "Marco D'Imperio and {Della Corte}, Anna and Angelo Facchiano and {Di Michele}, Michela and Gabriella Ferrandina and Donati, {Maria B.} and Domenico Rotilio",
year = "2010",
month = "5",
day = "7",
doi = "10.1016/j.jprot.2010.03.001",
language = "English",
volume = "73",
pages = "1355--1367",
journal = "Journal of Proteomics",
issn = "1874-3919",
publisher = "Elsevier B.V.",
number = "7",

}

TY - JOUR

T1 - Standardized sample preparation phases for a quantitative measurement of plasma peptidome profiling by MALDI-TOF

AU - D'Imperio, Marco

AU - Della Corte, Anna

AU - Facchiano, Angelo

AU - Di Michele, Michela

AU - Ferrandina, Gabriella

AU - Donati, Maria B.

AU - Rotilio, Domenico

PY - 2010/5/7

Y1 - 2010/5/7

N2 - A growing body of literature defines MALDI-TOF MS as a technique for studying plasma and serum, thus enabling the detection of proteins, and the generation of reproducible protein profile mass spectra, potentially able to discriminate correctly different biological systems. In this work, the different steps of the pre-analytical phase that may affect the reproducibility of plasma proteome analysis have been carefully considered. The results showed that the method is highly accurate (9.1%) and precise (8.9%) and the calibration curve for the ACTH (18-39), in human plasma, gave a good correlation coefficient (r > 0.99 and r2 > 0.98). The limit of detection (LOD) and the limit of quantification (LOQ), relative intensity, were of 0.5 × 10-9 M and 1.0 × 10-9 M respectively. Thus, an assay has been developed for the detection of low-abundant and low molecular weight proteins, from human plasma, aiming at the identification of new potential biomarkers. The method was tested on plasma from patients with a first diagnosis of pelvic mass. Statistical analysis of plasma profile generated a sub-profile of 17 peptides with their relative abundance able to discriminate patients bearing malignant or benign tumors. The sensitivity and specificity were 85.7% and 80.0% respectively.

AB - A growing body of literature defines MALDI-TOF MS as a technique for studying plasma and serum, thus enabling the detection of proteins, and the generation of reproducible protein profile mass spectra, potentially able to discriminate correctly different biological systems. In this work, the different steps of the pre-analytical phase that may affect the reproducibility of plasma proteome analysis have been carefully considered. The results showed that the method is highly accurate (9.1%) and precise (8.9%) and the calibration curve for the ACTH (18-39), in human plasma, gave a good correlation coefficient (r > 0.99 and r2 > 0.98). The limit of detection (LOD) and the limit of quantification (LOQ), relative intensity, were of 0.5 × 10-9 M and 1.0 × 10-9 M respectively. Thus, an assay has been developed for the detection of low-abundant and low molecular weight proteins, from human plasma, aiming at the identification of new potential biomarkers. The method was tested on plasma from patients with a first diagnosis of pelvic mass. Statistical analysis of plasma profile generated a sub-profile of 17 peptides with their relative abundance able to discriminate patients bearing malignant or benign tumors. The sensitivity and specificity were 85.7% and 80.0% respectively.

KW - Accuracy

KW - Biomarkers

KW - LOD-LOQ

KW - MALDI-TOF MS

KW - Plasma profile

KW - Precision

UR - http://www.scopus.com/inward/record.url?scp=77950918062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950918062&partnerID=8YFLogxK

U2 - 10.1016/j.jprot.2010.03.001

DO - 10.1016/j.jprot.2010.03.001

M3 - Article

C2 - 20227539

AN - SCOPUS:77950918062

VL - 73

SP - 1355

EP - 1367

JO - Journal of Proteomics

JF - Journal of Proteomics

SN - 1874-3919

IS - 7

ER -